GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ember Therapeutics Inc (OTCPK:EMBT) » Definitions » Shares Outstanding (Basic Average)

Ember Therapeutics (Ember Therapeutics) Shares Outstanding (Basic Average) : 3.71 Mil (As of Sep. 2015)


View and export this data going back to 2015. Start your Free Trial

What is Ember Therapeutics Shares Outstanding (Basic Average)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Ember Therapeutics's average basic shares outstanding for the quarter that ended in Sep. 2015 was 3.71 Mil.


Ember Therapeutics Shares Outstanding (Basic Average) Historical Data

The historical data trend for Ember Therapeutics's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ember Therapeutics Shares Outstanding (Basic Average) Chart

Ember Therapeutics Annual Data
Trend Dec12 Dec13 Dec14
Shares Outstanding (Basic Average)
3.71 3.71 3.71

Ember Therapeutics Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.71 3.71 3.71 3.71 3.71

Ember Therapeutics Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Ember Therapeutics  (OTCPK:EMBT) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Ember Therapeutics Shares Outstanding (Basic Average) Related Terms

Thank you for viewing the detailed overview of Ember Therapeutics's Shares Outstanding (Basic Average) provided by GuruFocus.com. Please click on the following links to see related term pages.


Ember Therapeutics (Ember Therapeutics) Business Description

Industry
Traded in Other Exchanges
N/A
Address
135 East 57th Street, 24th Floor, New York, NY, USA, 10022
Ember Therapeutics Inc is engaged in the healthcare sector. It is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies. It looks to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.

Ember Therapeutics (Ember Therapeutics) Headlines

From GuruFocus